Showing posts with label Sary Levy. Show all posts
Showing posts with label Sary Levy. Show all posts

Monday, February 01, 2016

IPR and Innovation 30, More on IPRI 2015 launching in KL last year

I am reposting this article from the Property Rights Index (PRA, Washington DC) last year, about the launching of IPRI 2015 in Kuala Lumpur that I attended. The photos I added and not part of the original PRA article.
-----------

Monday, November 16, 2015 | By Dennis Cakert

The 2015 International Property Rights Index (IPRI) was officially launched this morning in Kuala Lampur, hosted by Wan Saiful Wan Jan, Director of Southeast Asia Network for Development (SEANET). Today featured an introduction to the IPRI given by the Executive Director of the Property Rights Alliance, Lorenzo Montanari, followed by a presentation on this year’s findings by the 2014-2015 Hernando De Soto Fellow, Prof. Sary Levy Carciente….

Lorenzo Montanari released this statement earlier this morning:

“The 2015 IPRI emphasizes the necessity of property rights for creating a free market and driving economic growth” said Lorenzo Montanari, Executive Director of the Property Rights Alliance, “but we also recognize that property rights are first of all a matter of human rights. Property rights are directly related to the values and principles of individual liberty. The special case studies in this year’s edition demonstrate the importance of property rights for women and the poor in developing countries. This year data was available in countries where it was previously not, which is a good sign for future improvement. There are now 129 countries included in the analysis, up from 97 countries in last year’s edition. Countries that had strong property rights systems experienced significantly higher GDP per capita. In the EU, for example, IP accounts for 26 percent of employment and 39 percent of GDP. Societies undoubtedly achieve greater societal development by protecting property rights of authors, entrepreneurs, artists, innovators and inventors.”

There was also a presentation from Ganesh Muren, founder of Saora Industries, a Malaysian Innovative Social Enterprise that specializes in delivering safe and clean drinking water to rural and marginalised communities. Saora has innovated a proprietary solar powered water purification system that is able to purify any surface water (e.g. river water, rain water, pond) to safe clean drinking water through nanotechnology. The competitive advantage of Saora is their intellectual property. They have developed proprietary nanotechnology that replaces the usage of UV light to kill and eliminate bacteria and viruses. The affordability of this new technology developed by Saora makes it appealing and reachable to the poor, those at the “bottom of the pyramid”.

Mr. Burhan Irwan Cheong, Malaysia’s Lead Negotiator for the IP Chapter, Ministry for Domestic Trade, Cooperatices, and Consumerism, presented on the Intellectual Property Chapter in the TPPA and how it will implement a fair and transparent patent system in member countries. Young entrepreneurs like Ganesh Muren is a perfect example about how the TPPA will contribute to protecting the patent on his water purification system. Without the certainty of the rule of law, innovation does not exist.


Lastly, Bienvenido Oplas Jr., President of Minimal Government Thinkers in the Philippines and a SEANET Senior Fellow, presented his economic analysis on the benefits of the TPP for trade. His extensive research showed that if the Philippines joins the TPP, exports are expected to rise 48 percent and real GDP will increase 61 percent. He also spoke regarding the importance of property rights to maintain order in society, while debunking the myth that IP hurts public health, proving instead that government taxation of medicine is the real problem.
------------

Afternoon of that day, Dr. Sary Levy was interviewed in Bloomberg TV Malaysia, live. The place is outside KL proper.


The interviewer was a pretty and very articulate lady.


Among the footages shown while Prof. Levy was speaking. It's Wan, the CEO of IDEAS and Director of SEANET.

------------

See also:

Saturday, November 28, 2015

Free Trade 57, Growth, IPRI 2015 and the TPP

Two weeks ago, I attended the launching of  the International Property Rights Index (IPRI) 2015 Report in Kuala Lumpur, then I also gave a short presentation on IPR and the Trans Pacific Partnership (TPP) Agreement.


I showed portions of Dr. Ramon Clarete (University of the Philippines School of Economics, UPSE) paper during the UPSE-Ayala forum, Going Regional: Which Mega Trade Deals Should the Philippines Join? last February 2015.

He used the Gravity model of trade in estimating the level of bilateral exports or imports between two trading partners.

* Dependent variable: flow of trade between and among countries studied

* Independent or explanatory variables, their expected signs or relationships: GDP (+), population (+), dist. between two countries (-), commonality of language (+), shared borders (+), landlocked state (-).

* In addition, TPP and RCEP indicators or dummy variables are introduced: (a) TB1, 1 if both trading countries are TPP or RCEP members, 0 otherwise, (b) TB2, 1 if exporting country is a TPP or RCEP member, 0 otherwise; (c) TB3, 1 if importing country is a TPP or RCEP member, 0 otherwise. For overlapping memberships, a dummy variable where TPP*RCEP =1 if both trading partners are members of the two trade blocs.

And here are some results.


Then I briefly discussed my article in BusinessWorld that day, Property rights protection in APEC economies. Then I discussed the IPR on medicines aspect of the TPP.


And showed actual texts in the TPP agreement....


Below, from left: Lorenzo Montanari, Exec. Dir. of the Property Rights Alliance (PRA); Dr. Sary Levy, author of IPRI 2015, and Wan Saiful Wan Jan, CEO of IDEAS and Director, SEANET.




Concluding Notes:

1. Joining the TPP has more gains than pains for member-countries, especially in exports and overall GDP expansion.

2. IPR health provisions in TPP are not scary, they do not reduce access to cheaper generic drugs. Existing TRIPS flexibilities are maintained.

3. It seems that the generic pharma lobby + the anti-capitalism, anti-globalization NGOs created more noise and fear than what the TPPA actually provides.

4. There is more to fear in government taxation of medicines, in mandatory drug price discounts and price controls, than IPR protection.

“IPR create incentives for businesses to invest in ideas, to develop new products, and to earn a profit from the sale of those products. This in turn leads to improved customer satisfaction, improved profitability, and greater employment opportunities.”
– Prof. Sinclair Davidson, RMIT Univ. (Econ Dept.), Melbourne, Australia.

The full presentation is posted here.
------------

See also: